Preparing for China · patient guide

Imaging needed for a multiple myeloma review

There is no single imaging set that fits every multiple myeloma review. Which scans matter depends on your disease stage, what has changed, and the question you want answered. Send the original reports and images you already have, list the dates, and ask the treating haematologist which additional imaging, if any, they need before giving an opinion.

Go to the practical guidance ↓
AI illustration: A medical imaging room with a CT scanner, a desk with stacked folders and a pen, and a potted plant by the window.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Why imaging is central to a myeloma review, not an optional extra

Multiple myeloma is a cancer of plasma cells, and it can affect the skeleton in ways that blood tests alone do not show. Imaging helps the treating team see whether there is bone damage, how extensive it is, whether the spine is at risk, and whether a change in symptoms has a structural cause. That is why a records-based review usually needs more than a blood count and a protein electrophoresis result.

The International Myeloma Working Group describes whole-body low-dose CT as the preferred imaging technique for detecting myeloma bone disease, replacing the older skeletal survey where it is available. MRI remains important for the spine and for suspected spinal cord compression, and PET/CT has a role in certain situations. These are general statements from the guideline; which test applies to you is a clinical decision for your treating team.

For a review in China, the practical point is that the haematologist needs to see what has already been done and what it showed. A report alone can be enough for some questions, but for bone disease and spinal assessment the original images often matter. Ask the receiving team what format they can read before you send anything.

The imaging records most reviews will ask about

The exact list depends on your case, but these are the categories a haematologist commonly wants to see when reviewing myeloma. Treat this as a list of questions to put to the treating team, not a mandatory checklist you must complete before making contact.

Whole-body imaging: if you have had a whole-body low-dose CT, a skeletal survey, or a PET/CT, send the report and the images. The date matters, because a scan from two years ago and one from last month answer different questions.

Spine and bone MRI: if you have back pain, known vertebral lesions, or any concern about the spinal cord, MRI images of the relevant region are usually more informative than a report describing them. Send the images if you can.

Plain X-rays: older skeletal surveys may still be part of your file. They are less sensitive than low-dose CT for myeloma bone disease, but they show what was known at the time and can help the reviewer understand the trajectory.

Any imaging done for a specific symptom, such as a CT of the chest for breathlessness or an ultrasound for a palpable mass. These may not be myeloma-specific but can matter to the overall picture.

What each type of scan contributes, and its limits

Whole-body low-dose CT is fast, covers the whole skeleton, and exposes the patient to a lower radiation dose than a standard diagnostic CT. The IMWG position is that it should replace the conventional skeletal survey for detecting lytic bone disease. It does not replace MRI for assessing the spinal cord or for looking at soft tissue in detail.

MRI is one of the imaging options used to assess bone and bone marrow lesions in myeloma. Whether MRI is needed, and which region should be scanned, is a decision for the treating team.

PET/CT is one of the imaging options that may be used in myeloma. It is not a routine first test for everyone, and its role should be defined by the haematologist managing your case.

None of these scans diagnoses myeloma on its own. The diagnosis and the treatment decision rest on the combination of blood and urine tests, bone marrow examination, imaging and the clinical picture. A reviewer looking at images without the laboratory results is working with part of the picture.

How to send imaging records for a review in China

Most hospitals outside China issue imaging on a CD or DVD, or through a patient portal. Ask the receiving team which format they can open and whether they need the original disc or a secure upload. Do not assume that a photograph of a report is sufficient for a bone or spine question.

A practical approach is to send a short summary first: the diagnosis, the date of diagnosis, the treatment you have had, your current symptoms, and a list of the imaging you hold with dates. The free initial review can check whether that summary is clear and what appears to be missing. It is not a diagnosis and does not confirm that a hospital will accept you.

After that first contact, the team can tell you how to share larger files. Do not send passport numbers, payment details or a complete medical archive through an initial enquiry form.

If your images are only available in a format the receiving hospital cannot read, ask the original imaging centre for a copy in a standard format such as DICOM. This is a request to the imaging provider, not something a coordinator can create.

Questions to put to the treating haematologist before you travel

The value of a review depends on asking the right questions. These are worth putting in writing to the team that will look at your records.

Which imaging do you need to see, and in what format? Is my existing whole-body imaging sufficient, or would you want it repeated? If a repeat is needed, can it be done locally before travel, and would you accept those images? What is the radiation exposure of any new scan, and are there alternatives? If I have back pain or any neurological symptom, what should I do before travelling?

A records-based opinion from a specialist can address some of these questions, but it cannot replace an in-person examination. A proxy consultation is optional and is not a prerequisite for an appointment. The hospital decides whether it can assess you and what it needs.

Safety comes before scheduling

New or worsening back pain, leg weakness, numbness, or any change in bladder or bowel control in someone with myeloma should be assessed urgently by your local treating team. Do not wait for an overseas review or a travel date to have these symptoms looked at. The same applies to sudden severe pain or a suspected fracture.

Imaging findings need to be interpreted alongside your blood results, bone marrow findings and symptoms. A reviewer in China can offer an opinion on the records you send, but the treating team where you are now remains responsible for your immediate care. If you are mid-treatment, ask your current team before making any change to your plan.

The hospital in China decides whether it can accept you and what further tests it requires. A review does not establish eligibility for a clinical trial, a transplant or any particular therapy, and availability of a treatment is confirmed only by the treating hospital.

A practical next step

Start with a short summary of your diagnosis, treatment history, current symptoms and a dated list of the imaging you hold. The initial case review is free and can tell you what appears to be missing and which next step may fit. You can then ask the treating haematologist which images they need and in what format before deciding whether to travel. Further reading on the condition and its treatment is available in the multiple myeloma care reference and the blood disorder and blood cancer care specialty pages.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. payment
  2. blood disorder and blood cancer care
  3. Related treatment reference
  4. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
  5. Overview | Myeloma: diagnosis and management | Guidance | NICE
  6. Myeloma - NHS

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.